Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

Oakley C. Olson,Johanna A. Joyce

DOI: https://doi.org/10.1038/nrc4027

IF: 78.5

2015-11-24

Nature Reviews Cancer

Abstract:Key PointsIn many cancer types cathepsin proteases are upregulated and display altered trafficking and localization. Increased cathepsin expression generally correlates with increased malignancy and poor patient prognosis.Secretion of cathepsin proteases by cancer cells and infiltrating immune cells into the extracellular space disrupts intercellular adhesion complexes, induces angiogenesis and drives local invasion by tumour cells.Genetic experiments have identified crucial non-redundant roles for individual cathepsin proteases in the tumorigenesis of multiple genetically engineered mouse models.The pro- or antitumorigenic properties of individual cathepsins are context dependent and specific to the tissue and cell of origin or site of metastasis.Cathepsin activity exists within a larger integrated network of protease activity known as the protease web. Through interactions with other proteases and their inhibitors, cathepsins can alter general proteolytic activity within the tumour microenvironment.Cathepsin proteases have demonstrated roles in intrinsic and acquired resistance to radiation and chemotherapy. Concurrent inhibition of cathepsins with different therapeutic modalities improves outcome in preclinical models.

oncology